Seattle Genetics (SGEN) PT Lowered to $64 at Piper Jaffray

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GOOGL
8. GMAB
9. USO
10. AMD

Go back to Seattle Genetics (SGEN) PT Lowered to $64 at Piper Jaffray

Seattle Genetics (SGEN) Misses Q4 EPS by 32c, Revenues Beat; Offers FY19 Revenue Guidance Below Consensus

February 7, 2019 4:05 PM EST

Seattle Genetics (NASDAQ: SGEN) reported Q4 EPS of ($0.75), $0.32 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $174.51 million versus the consensus estimate of $163.71 million.

During 2018, we received FDA approval for two ADCETRIS frontline indications, a major accomplishment that significantly expands the number of patients eligible to benefit from... More